MPLT

MPLT EBITDA Growth

-153.52%TTM

Period ending:

MPLT TTM EBITDA YoY %%
MPLT TTM EBITDA YoY %-38.66%-165.83%
2025-09-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

MPLT ebitda growth history

Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 4 observations from Sep 30, 2025 to Jun 30, 2026.

Maplight Therapeutics Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-153.52%
-147.8147%
-108.8646%
-50.9668%

Compare ebitda growth

All MPLT financial metrics · MPLT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.